PDSA and its members have submitted a letter request the FDA to issue formal clarification of 3PL licensure status, as stated in the DSCSA, in written form through guidance, press… Read More →
The Pharmaceutical Distribution Security Alliance (PDSA) has released “A Proposal: Governance for DSCSA Phase II Interoperability,” the first in a series of White Papers. Through this series of papers, PDSA… Read More →
HDMA is the national association representing primary pharmaceutical distributors, the vital link between the nation’s pharmaceutical manufacturers and healthcare providers. HDMA reviews key priority issues and advocates on behalf of… Read More →
National uniformity is established through the DSCSA by preempting certain state requirements related to product tracing, licensure of wholesale distributors, and licensure of 3PLs. The DSCSA requires a common understanding and approach from… Read More →
PDSA and its members have considered and evaluated what we believe to be the most appropriate approaches to exceptions and grandfathering. PDSA offered these comments and suggestions to FDA to assist the… Read More →
We are a coalition of more than 30 stakeholders spanning the supply chain spectrum – including biologic and pharmaceutical manufacturers, distributors, pharmacies, and logistics providers.
Learn More →